HHS Press Releases

• Published on November 24, 2020 - 14:37 GMT

  

  Statement from HHS Chief of Staff Brian Harrison on Efforts to Increase Transparency at HHS

  Today, the Department of Health and Human Services (HHS) through a Notice published in the Federal Register announced a policy to enhance transparency at HHS by requiring that all assumptions, working papers, models, and other information used as part of …

  Distribution channels: Healthcare & Pharmaceuticals Industry
• Published on November 23, 2020 - 22:41 GMT

  

  HHS and DOD Award $11.6 Million Contract to Puritan Medical Products to Boost U.S. Production of Swabs for Cue Health COVID-19 ...

  The U.S. Department of Health and Human Services (HHS) and the U.S. Department of Defense (DOD) have jointly awarded an $11.6 million contract to Puritan Medical Products Company, LLC, to expand domestic production capacity of Cue Sample Wands, the nasal …

  Distribution channels: Healthcare & Pharmaceuticals Industry
• Published on November 23, 2020 - 20:16 GMT

  

  HHS Allocates Regeneron Therapeutic to Treat Patients With Mild to Moderate COVID-19

  The U.S. Department of Health and Human Services today announced plans to allocate initial doses of Regeneron’s investigational monoclonal antibody therapeutic, casirivimab and imdevimab, which received emergency use authorization from the U.S. Food and …

  Distribution channels: Healthcare & Pharmaceuticals Industry
• Published on November 21, 2020 - 01:00 GMT

  Secretary Azar Statement on Final Rule to Increase Access to Lifesaving Organs

  Today, the Department of Health and Human Services, through the Centers for Medicare & Medicaid Services (CMS), is finalizing a rule that is designed to increase the supply of lifesaving organs available for transplant in the United States by requiring …

  Distribution channels: Healthcare & Pharmaceuticals Industry
• Published on November 20, 2020 - 22:14 GMT

  

  HHS Makes Stark Law and Anti-Kickback Statute Reforms to Support Coordinated, Value-Based Care

  Today, the Department of Health and Human Services (HHS) published two final rules that aim to reduce regulatory barriers to care coordination and accelerate the transformation of the healthcare system into one that pays for value and promotes the delivery …

  Distribution channels: Healthcare & Pharmaceuticals Industry
• Published on November 20, 2020 - 20:51 GMT

  

  Statement from HHS Chief of Staff Brian Harrison on Unapproved Drugs Initiative

  Today, the Department of Health and Human Services (HHS) through a Notice published in the Federal Register announced the withdrawal of guidance documents issued as part of the Unapproved Drugs Initiative. HHS Chief of Staff Brian Harrison issued the …

  Distribution channels: Healthcare & Pharmaceuticals Industry
• Published on November 20, 2020 - 20:08 GMT

  

  HHS Drug Pricing Fact Sheet

  The President has promised the American people better care, more choices, and lower costs. These drug pricing actions deliver on all three fronts and key goals of the American Patients First blueprint. – HHS Secretary Alex Azar President Trump is …

  Distribution channels: Healthcare & Pharmaceuticals Industry
• Published on November 20, 2020 - 20:08 GMT

  

  HHS Finalizes Rule to Bring Drug Discounts Directly to Seniors at the Pharmacy Counter

  Today, in response to President Trump’s July 24, 2020 Executive Order on “Lowering Prices for Patients by Eliminating Kickbacks to Middlemen,” HHS Secretary Alex Azar and the HHS Office of Inspector General finalized a regulation to eliminate the current …

  Distribution channels: Healthcare & Pharmaceuticals Industry
• Published on November 20, 2020 - 20:08 GMT

  

  Fact Sheet: Trump Administration Finalizes Proposal to Lower Drug Costs by Targeting Backdoor Rebates and Encouraging Direct ...

  Directed by President Trump's July 24, 2020 Executive Order on "Lowering Prices for Patients by Eliminating Kickbacks to Middlemen," the Department of Health and Human Services Secretary Alex Azar and the HHS Office of Inspector General (OIG) …

  Distribution channels: Healthcare & Pharmaceuticals Industry
• Published on November 20, 2020 - 20:08 GMT

  

  Secretary Azar Confirmation In Response to Executive Order on Lowering Prices for Patients by Eliminating Kickbacks to Middlemen

  President Trump has made it a priority to decrease the costs of prescription drugs for Americans, and he has never wavered from this commitment. The President has taken bold action from protecting the ability of pharmacists to help patients fill …

  Distribution channels: Healthcare & Pharmaceuticals Industry
• Published on November 20, 2020 - 20:08 GMT

  

  Trump Administration Announces Prescription Drug Payment Model to Put American Patients First

  In support of President Trump's historic commitment to lowering drug prices for American patients, HHS Secretary Alex Azar announced a drug payment model through the Center for Medicare and Medicaid Innovation at the Centers for Medicare & Medicaid …

  Distribution channels: Healthcare & Pharmaceuticals Industry
• Published on November 20, 2020 - 15:32 GMT

  

  HHS Provides $25 Million to Siemens Healthineers to Develop and Produce COVID-19 Antigen Diagnostic Tests

  Today, the U.S. Department of Health and Human Services (HHS) and the U.S. Department of Defense (DoD) awarded Siemens Healthineers a $12 million contract to support domestic production of two diagnostic tests for SARS-CoV-2, the virus that causes COVID-19 …

  Distribution channels: Healthcare & Pharmaceuticals Industry
• Published on November 19, 2020 - 18:45 GMT

  

  HHS Office for Civil Rights Reaches Landmark Agreement with Massachusetts Department of Children and Families to Address ...

  The U.S. Department of Health and Human Services (HHS) and the U.S. Department of Justice (DOJ) announced today that they have reached a landmark agreement with the Massachusetts Department of Children and Families (DCF). The agreement resolves findings by …

  Distribution channels:
• Published on November 19, 2020 - 17:27 GMT

  

  OCR Settles Twelfth Investigation in HIPAA Right of Access Initiative

  The Office for Civil Rights (OCR) at the U.S. Department of Health and Human Services (HHS) announces its twelfth settlement of an enforcement action in its HIPAA Right of Access Initiative. OCR announced this initiative as an enforcement priority in 2019 …

  Distribution channels: Healthcare & Pharmaceuticals Industry
• Published on November 19, 2020 - 13:23 GMT

  

  HHS Launches Pilot Program of Fast Molecular POC Test for COVID-19

  The U.S. Department of Health and Human Services (HHS) has launched a pilot program with five states to use portable, cartridge-based COVID-19 molecular test kits that provide rapid results. The pilot program will assess how to best integrate diagnostic …

  Distribution channels: Healthcare & Pharmaceuticals Industry
• Published on November 18, 2020 - 16:02 GMT

  

  Secretary Alex Azar Statement on FDA Authorization of First COVID-19 Test for Home Self-Tests

  On Tuesday, the Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for the first COVID-19 diagnostic at-home test, the Lucira COVID-19 All-In-One Test Kit, a molecular test that provides results in 30 minutes or less and is …

  Distribution channels: Healthcare & Pharmaceuticals Industry
• Published on November 17, 2020 - 19:22 GMT

  

  HHS Launches First-of-its-Kind Regulatory Clean-Up Initiative Utilizing AI

  The Department of Health and Human Services (HHS) has issued a final rule as part of a new department-wide regulatory clean-up initiative, the first of its kind utilizing artificial intelligence (AI) and natural language processing (NLP) technologies, …

  Distribution channels: Healthcare & Pharmaceuticals Industry
• Published on November 17, 2020 - 17:00 GMT

  

  HHS Seeks Public Input on Leveraging Novel Technologies for Chronic Disease Management for Aging Underserved Populations

  In an effort to improve access to emerging technologies and healthcare services, the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Health (OASH), in partnership with federal agencies, has issued a Request for …

  Distribution channels: Healthcare & Pharmaceuticals Industry
• Published on November 16, 2020 - 13:05 GMT

  

  HHS Secretary Azar Statement on Moderna Vaccine Announcement

  On Monday, the National Institutes of Health announced that an independent data and safety monitoring board’s interim review of data from Moderna’s investigational COVID-19 vaccine suggests that the vaccine is safe and effective at preventing symptomatic …

  Distribution channels: Healthcare & Pharmaceuticals Industry
• Published on November 13, 2020 - 14:30 GMT

  

  HHS OCR Provides Technical Assistance to Ensure New Jersey Department of Children and Families Protect Parents with Disabilities ...

  Today, the Office for Civil Rights (OCR) at the U.S. Department of Health and Human Services announces that it has provided technical assistance to the New Jersey Department of Children and Families (DCF) to ensure that parents with disabilities are …

  Distribution channels: